BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 36359789)

  • 21. B-cell receptor signaling inhibitors for treatment of autoimmune inflammatory diseases and B-cell malignancies.
    Puri KD; Di Paolo JA; Gold MR
    Int Rev Immunol; 2013 Aug; 32(4):397-427. PubMed ID: 23886342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD22 regulates adaptive and innate immune responses of B cells.
    Kawasaki N; Rademacher C; Paulson JC
    J Innate Immun; 2011; 3(4):411-9. PubMed ID: 21178327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B cell receptor repertoire abnormalities in autoimmune disease.
    Yuuki H; Itamiya T; Nagafuchi Y; Ota M; Fujio K
    Front Immunol; 2024; 15():1326823. PubMed ID: 38361948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A balance between B cell receptor and inhibitory receptor signaling controls plasma cell differentiation by maintaining optimal Ets1 levels.
    Luo W; Mayeux J; Gutierrez T; Russell L; Getahun A; Müller J; Tedder T; Parnes J; Rickert R; Nitschke L; Cambier J; Satterthwaite AB; Garrett-Sinha LA
    J Immunol; 2014 Jul; 193(2):909-920. PubMed ID: 24929000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Facultative role for T cells in extrafollicular Toll-like receptor-dependent autoreactive B-cell responses in vivo.
    Sweet RA; Ols ML; Cullen JL; Milam AV; Yagita H; Shlomchik MJ
    Proc Natl Acad Sci U S A; 2011 May; 108(19):7932-7. PubMed ID: 21518858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The establishment of early B cell tolerance in humans: lessons from primary immunodeficiency diseases.
    Meffre E
    Ann N Y Acad Sci; 2011 Dec; 1246():1-10. PubMed ID: 22236425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous immunoglobulin induces a functional silencing program similar to anergy in human B cells.
    Séïté JF; Goutsmedt C; Youinou P; Pers JO; Hillion S
    J Allergy Clin Immunol; 2014 Jan; 133(1):181-8.e1-9. PubMed ID: 24139609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple paths to loss of anergy and gain of autoimmunity.
    Conrad FJ; Rice JS; Cambier JC
    Autoimmunity; 2007 Sep; 40(6):418-24. PubMed ID: 17729035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toll-like receptor driven B cell activation in the induction of systemic autoimmunity.
    Green NM; Marshak-Rothstein A
    Semin Immunol; 2011 Apr; 23(2):106-12. PubMed ID: 21306913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of inhibitory BCR co-receptors in immunity.
    Tsubata T
    Infect Disord Drug Targets; 2012 Jun; 12(3):181-90. PubMed ID: 22394175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulatory strategies limiting endosomal Toll-like receptor activation in B cells.
    Acharya M; Jackson SW
    Immunol Rev; 2022 May; 307(1):66-78. PubMed ID: 35040152
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Engagement of the B cell receptor for antigen differentially affects B cell responses to Toll-like receptor-7 agonists and antagonists in BXSB mice.
    Layer T; Steele A; Goeken JA; Fleenor S; Lenert P
    Clin Exp Immunol; 2011 Mar; 163(3):392-403. PubMed ID: 21235537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TNF receptor-associated factor 3 restrains B-cell receptor signaling in normal and malignant B cells.
    Whillock AL; Ybarra TK; Bishop GA
    J Biol Chem; 2021; 296():100465. PubMed ID: 33639170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. B cell receptor (BCR) endocytosis.
    Roberts AD; Taraska JW
    Prog Mol Biol Transl Sci; 2023; 194():159-177. PubMed ID: 36631191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pivotal position of the actin cytoskeleton in the initiation and regulation of B cell receptor activation.
    Song W; Liu C; Upadhyaya A
    Biochim Biophys Acta; 2014 Feb; 1838(2):569-78. PubMed ID: 23886914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pyruvate Kinase M2 Contributes to TLR-Mediated Inflammation and Autoimmunity by Promoting Pyk2 Activation.
    Zhang X; Yang Y; Jing L; Zhai W; Zhang H; Ma Q; Li C; Yan F; Cheng D; Zhang J; Ning Z; Shi H; Wang C; Zhao M; Dai J; Li Z; Ming J; Yu M; Wang H; Cheng H; Xiong H; Dong G
    Front Immunol; 2021; 12():680068. PubMed ID: 34025679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nucleic acid recognizing Toll-like receptors and autoimmunity.
    von Landenberg P; Bauer S
    Curr Opin Immunol; 2007 Dec; 19(6):606-10. PubMed ID: 18060756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BCR and Endosomal TLR Signals Synergize to Increase AID Expression and Establish Central B Cell Tolerance.
    Kuraoka M; Snowden PB; Nojima T; Verkoczy L; Haynes BF; Kitamura D; Kelsoe G
    Cell Rep; 2017 Feb; 18(7):1627-1635. PubMed ID: 28199836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defective antigen-receptor-mediated regulation of immunoglobulin production in B cells from autoimmune strains of mice.
    Anderson CC; Cairns E; Rudofsky UH; Sinclair NR
    Cell Immunol; 1995 Aug; 164(1):141-9. PubMed ID: 7634346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of autoreactive B cells: checkpoints and activation.
    Ding C; Yan J
    Arch Immunol Ther Exp (Warsz); 2007; 55(2):83-9. PubMed ID: 17347802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.